Logos Global Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.6M Buy
3,850,000
+350,000
+10% +$3.34M 1.68% 20
2025
Q4
$42.5M Buy
3,500,000
+250,000
+8% +$3.04M 2.83% 9
2025
Q3
$38M Buy
3,250,000
+1,050,000
+48% +$12.6M 3.75% 6
2025
Q2
$20.4M Sell
2,200,000
-100,000
-4% -$783K 2.73% 14
2025
Q1
$16.9M Sell
2,300,000
-1,200,000
-34% -$9.22M 3% 14
2024
Q4
$29.9M Hold
3,500,000
3.5% 10
2024
Q3
$30.4M Sell
3,500,000
-1,650,000
-32% -$13.6M 3.41% 10
2024
Q2
$35.2M Sell
5,150,000
-661,436
-11% -$4.08M 4.06% 10
2024
Q1
$52M Buy
5,811,436
+1,811,436
+45% +$12.9M 5.47% 6
2023
Q4
$17.8M Buy
+4,000,000
New +$11.8M 1.98% 19

Other funds holding OCUL